Overview
- 8 FDA inspections are on record.
- 3 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-04-01.
At a glance
Inspections
8
Form 483s
3
EIRs
5
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 24 Mar 2026 – 1 Apr 2026 | Human Drugs | 483 | On file |
| 11 Jun 2024 – 18 Jun 2024 | Human Drugs | 483 | On file |
| 10 Jan 2022 – 13 Jan 2022 | Human Drugs | Clean | |
| 23 Sep 2020 – 29 Sep 2020 | Human Drugs | 483 | On file |
| 9 Apr 2018 – 11 Apr 2018 | Human Drugs | Clean | |
| 14 Jul 2015 – 16 Jul 2015 | Human Drugs | Clean | |
| 29 Aug 2012 | Not recorded | Clean | |
| 9 Oct 2009 | Not recorded | Clean |
Investigators
FDA investigators tied to this site in the record.
Viviana Matta2 insp.
Marian E Ramirez1 insp.
Yoriann M Cabrera Bartolomei1 insp.
Michael Shanks1 insp.
Olumide A Martins1 insp.
Ayyappan Rathakrishnan1 insp.
Kamal N Tiwari1 insp.
Seneca D Toms1 insp.
Adam R Cooke1 insp.
Lillie D Witcher1 insp.
Lauryl A Smith1 insp.
Daveta L Bailey1 insp.
Lesley K Satterwhite1 insp.
Ibad U Khan1 insp.
Jose M Gonzalez1 insp.
Full site report
Get the verbatim findings behind KBI Biopharma, Inc.'s 3 Form 483s
The full inspection record, as Atlas holds it, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat